Uncontrolled Asthma

Disease State Hub

FDA Alerts

FDA Alert

FDA Alert

FDA Approves First Generic Fluticasone Propionate Inhalation Aerosol for Asthma Maintenance Therapy in Patients Aged 4 Years and Older

03/03/2026

Anthony Calabro, MA

On March 3, 2026, the FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg per actuation, for the maintenance treatment of asthma as prophylactic therapy in...

03/03/2026

Research Summaries

FDA Alert

FDA Approves First Generic Fluticasone Propionate Inhalation Aerosol for Asthma Maintenance Therapy in Patients Aged 4 Years and Older

03/03/2026

Anthony Calabro, MA

03/03/2026

Research Summary

Research Summary

As-Needed Albuterol–Budesonide in Mild Asthma

06/13/2025

Miranda Manier, BA

A phase 3b trial evaluated as-needed albuterol–budesonide versus albuterol alone in patients with uncontrolled mild asthma.

06/13/2025

asthma

In Uncontrolled Asthma, Blood Eosinophils May Hint at Lung Function

02/25/2019

Researchers assessed the eosinophil levels and lung function of individuals with low FEV1 reversibility to SABA. The study was presented at the 2019 AAAAI Annual Meeting.

02/25/2019

Medication Prescribing

Does Tralokinumab Improve Uncontrolled Asthma Outcomes?

07/02/2018

In a new study, researchers sought to examine the role of interleukin 13 in airway inflammation in asthma, as well as the effects of tralokinumab on airway eosinophilic infiltration, blood and sputum...

07/02/2018

asthma

Comorbidities Are Common Among Patients With Uncontrolled Asthma

07/24/2017

Previous research has indicated that comorbidities contribute to uncontrolled asthma. In a new study, the researchers sought to investigate this relationship further in order to help improve treatment...

07/24/2017

April 2026

Current Issue

April 2026